Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 39

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 39
---
 and all other classes or series of parity preferred stock and upon which
like voting rights have been conferred and are exercisable) will be entitled to elect two additional directors at a special meeting called
upon the request of at least 10% of such holders (together with any other class or series of parity preferred stock upon which like voting
rights have been conferred and are exercisable) or at our next annual meeting and each subsequent annual meeting of stockholders, each
additional director being referred to as a “Preferred Stock Director,” until all unpaid dividends with respect to the Series B
Preferred Stock and such other classes or series of preferred stock with like voting rights have been paid. Preferred Stock Directors
will be elected by a plurality of the votes cast by the outstanding Series B Preferred Stock and any other series of parity equity
shares with like voting rights, voting together as a single class. Special meetings called in accordance with the provisions described
in this paragraph shall be subject to the procedures in our bylaws, except that we, rather than the holders of Series B Preferred
Stock or any other class or series of parity preferred stock entitled to vote thereon when they have the voting rights described above
(voting together as a single class), will pay all costs and expenses of calling and holding the meeting.

<div align='center'>S-22</div>

Any Preferred Stock Director may be removed at
any time with or without cause by the vote of, and may not be removed otherwise than by the vote of, the holders of record of a majority
of the outstanding Series B Preferred Stock and all other classes or series of parity preferred stock entitled to vote thereon when
they have the voting rights described above (voting together as a single class). So long as a dividend arrearage continues, any vacancy
in the office of a Preferred Stock Director may be filled by written consent of the Preferred Stock Director remaining in office, or if
none remains in office, by a plurality of the votes cast by the outstanding Series B Preferred Stock when they have the voting rights
described above (voting as a single class with all other classes or series of parity preferred stock upon which like voting rights have
been conferred and are exercisable).

So long as any shares of Series B Preferred
Stock remain outstanding, we will not, without the affirmative vote or written consent of the holders of at least two-thirds of the then
outstanding shares of Series B Preferred Stock and each other class or series of parity preferred stock with like voting rights (